Back
Speaker illustration

Doctor Tianshu Gu

Tianjin (China)

Presentations

The impact of pre-myocardial infarction exercise frequency on prognosis in Non-ST segment elevation myocardial infarction patients

Event: ESC Congress 2024

Topic: Non-ST-Elevation Myocardial Infarction (NSTEMI)

Session: Acute and chronic coronary syndromes

Access
Like
Thumbnail

Antiplatelet can improve the short-term prognosis of type 2 myocardial infarction caused by acute respiratory failure

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Data-driven decisions for anticoagulant and antiplatelet therapy

Access
Like
Thumbnail

Both fibrosis-4 index and fibrosis-5 index can predict the prognosis of patients after percutaneous coronary intervention

Event: ESC Congress 2024

Topic: Outcome

Session: All things percutaneous coronary intervention: a potpourri of percutaneous coronary intervention-related topics

Access
Like
Thumbnail

Ticagrelor vs. clopidogrel in ST elevation myocardial infarction patients with hemoglobin > 160

Event: ESC Congress 2024

Topic: ST-Elevation Myocardial Infarction (STEMI)

Session: Bleeding and antiplatelet strategies in acute coronary syndromes

Access
Like
Thumbnail

Levosimendan improves the early prognosis of patients with Non ST-segment elevation myocardial infarction and Killip class > II

Event: ESC Congress 2024

Topic: Pharmacotherapy

Session: Pharmacotherapy in coronary artery disease: from bench to bedside (2)

Access
Like
Thumbnail

The impact of pre-myocardial infarction exercise frequency on prognosis in acute myocardial infarction patients

Event: ESC Congress 2024

Topic: Exercise

Session: Lifestyle, obesity, and dyslipidaemia

Access
Like
Thumbnail

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources